New Journey Health Technology GroupLTD Past Earnings Performance
Past criteria checks 1/6
New Journey Health Technology GroupLTD has been growing earnings at an average annual rate of 63.9%, while the Healthcare industry saw earnings growing at 4.2% annually. Revenues have been declining at an average rate of 1.4% per year. New Journey Health Technology GroupLTD's return on equity is 1.8%, and it has net margins of 0.9%.
Key information
63.9%
Earnings growth rate
64.7%
EPS growth rate
| Healthcare Industry Growth | 7.0% |
| Revenue growth rate | -1.4% |
| Return on equity | 1.8% |
| Net Margin | 0.9% |
| Last Earnings Update | 31 Mar 2024 |
Revenue & Expenses BreakdownBeta
How New Journey Health Technology GroupLTD makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 3,668 | 33 | 859 | 31 |
| 31 Dec 23 | 3,590 | 31 | 862 | 28 |
| 30 Sep 23 | 3,433 | 88 | 932 | 15 |
| 30 Jun 23 | 3,238 | 162 | 859 | 1 |
| 31 Mar 23 | 3,170 | 176 | 787 | 0 |
| 01 Jan 23 | 3,161 | 156 | 744 | 0 |
| 30 Sep 22 | 3,118 | -200 | 781 | 0 |
| 30 Jun 22 | 3,058 | -272 | 802 | 0 |
| 31 Mar 22 | 3,079 | -323 | 811 | 0 |
| 01 Jan 22 | 3,016 | -371 | 822 | 0 |
| 30 Sep 21 | 3,022 | -62 | 700 | -1 |
| 30 Jun 21 | 3,029 | -54 | 663 | -1 |
| 31 Mar 21 | 2,954 | -68 | 649 | 0 |
| 31 Dec 20 | 2,806 | -52 | 597 | 0 |
| 30 Sep 20 | 2,953 | -2,399 | 1,649 | 2 |
| 30 Jun 20 | 3,088 | -2,506 | 1,695 | 3 |
| 31 Mar 20 | 3,302 | -2,577 | 1,680 | 1 |
| 31 Dec 19 | 3,684 | -2,520 | 1,798 | 1 |
| 30 Sep 19 | 3,806 | -1,201 | 1,057 | 9 |
| 30 Jun 19 | 3,829 | -1,551 | 1,120 | 8 |
| 31 Mar 19 | 3,829 | -1,442 | 1,110 | 9 |
| 31 Dec 18 | 3,838 | -1,418 | 1,107 | 8 |
| 30 Sep 18 | 4,168 | -436 | 905 | 0 |
| 30 Jun 18 | 4,152 | 110 | 772 | 0 |
| 31 Mar 18 | 3,853 | 182 | 733 | 0 |
| 31 Dec 17 | 3,399 | 203 | 594 | 0 |
| 30 Sep 17 | 2,966 | 454 | 413 | 0 |
| 30 Jun 17 | 2,511 | 425 | 362 | 0 |
| 31 Mar 17 | 2,288 | 403 | 350 | 0 |
| 31 Dec 16 | 2,175 | 404 | 327 | 0 |
| 30 Sep 16 | 1,637 | 335 | 265 | 0 |
| 30 Jun 16 | 1,532 | 386 | 227 | 0 |
| 31 Mar 16 | 1,386 | 343 | 205 | 0 |
| 31 Dec 15 | 1,182 | 324 | 172 | 0 |
| 30 Sep 15 | 905 | 229 | 138 | 0 |
| 30 Jun 15 | 744 | 179 | 111 | 0 |
| 31 Mar 15 | 681 | 236 | 100 | 0 |
| 31 Dec 14 | 686 | 257 | 95 | 0 |
| 30 Sep 14 | 679 | 251 | 96 | 0 |
| 30 Jun 14 | 617 | 225 | 128 | 0 |
| 31 Mar 14 | 574 | 194 | 141 | 0 |
| 31 Dec 13 | 565 | 170 | 173 | 0 |
| 30 Sep 13 | 502 | 157 | 156 | 0 |
| 30 Jun 13 | 484 | 143 | 157 | 0 |
Quality Earnings: 002219 has a large one-off loss of CN¥19.8M impacting its last 12 months of financial results to 31st March, 2024.
Growing Profit Margin: 002219's current net profit margins (0.9%) are lower than last year (5.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002219 has become profitable over the past 5 years, growing earnings by 63.9% per year.
Accelerating Growth: 002219's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 002219 had negative earnings growth (-81%) over the past year, making it difficult to compare to the Healthcare industry average (-1%).
Return on Equity
High ROE: 002219's Return on Equity (1.8%) is considered low.